| Upcoming events on GETINGE AB |
|
| 01/28/21 | 08:00am | | Jahr 2020 Ergebnisveröffentlichung |
| 01/28/21 | 10:00am | | Jahr 2020 Präsentation des Ergebnisses |
| 02/04/21 | | TCS ECMO Congress |
| 03/07/21 | | European Vascular Course Conference |
|
| Past events on GETINGE AB |
|
| 12/05/20 | | ESICM LIVES Conference |
| 11/28/20 | | European Society of Anaesthesiology Conference |
| 11/26/20 | | International Fluid Academy Days Conference |
| 11/10/20 | | Pharmtech&Ingredients International Conference |
|
| Upcoming sector events for GETINGE AB |
|
|
| |
|
| Past sector events for GETINGE AB |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M SEK |
Released
Forecast
Spread | 30 235
30 093
0,47% | 29 756
29 847
-0,30% | 22 495
22 421
0,33% | 24 172
24 155
0,07% | 26 559
26 525
0,13% |
29 992
|
Operating income
(EBITDA)
M SEK |
Released
Forecast
Spread | 5 877
5 732
2,5% | 6 303
5 592
13% | 5 159
4 672
10% | 3 916
3 724
5,2% | 4 986
4 662
7,0% |
7 245
|
Operating profit
(EBIT)
M SEK |
Released
Forecast
Spread | 3 718
3 476
7,0% | 3 600
3 929
-8,4% | 2 256
3 003
-25% | 2 216
2 180
1,7% | 2 813
2 546
11% |
5 020
|
Pre-Tax Profit
(EBT)
M SEK |
Released
Forecast
Spread | 1 997
2 246
-11% | 1 650
1 879
-12% | 933
1 535
-39% | -624
-744
16% | 1 909
1 808
5,6% |
4 416
|
Net income
M SEK |
Released
Forecast
Spread | 1 390
1 600
-13% | 1 213
1 347
-9,9% | 1 376
1 128
22% | -967
-847
-14% | 1 222
1 360
-10% |
3 192
|
EPS
SEK |
Released
Forecast
Spread | 5,83
6,75
-14% | 4,98
5,71
-13% | 5,49
4,46
23% | -3,55
-3,03
-17% | 4,48
4,64
-3,4% |
11,6
| | Announcement Date | 01/28/2016 | 01/26/2017 | 01/29/2018 | 01/30/2019 | 01/30/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M SEK |
Released
Forecast
Spread | 5 731
5 589
2,5% | 5 683
5 440
4,5% | 7 890
8 017
-1,6% | 5 548
5 297
4,7% | 6 277
6 164
1,8% | 6 236
6 052
3,0% | 8 498
8 497
0,01% | 6 033
6 033
0,00% | 6 971
6 971
0,00% | 7 976
7 992
-0,20% |
8 766
|
6 117
|
6 208
|
7 021
|
8 243
|
Operating income
(EBITDA)
M SEK |
Released
Forecast
Spread | 833
882
-5,5% | 757
648
17% | 1 735
1 545
12% | 767
794
-3,4% | 1 002
1 009
-0,71% | 1 101
948
16% | 2 116
1 954
8,3% | 1 076
1 041
3,3% | 1 669
1 353
23% | 2 453
2 120
16% |
2 199
|
|
|
|
|
Operating profit
(EBIT)
M SEK |
Released
Forecast
Spread | 405
406
-0,14% | 323
212
52% | 1 285
1 190
8,0% | 247
356
-31% | 466
432
7,8% | 554
478
16% | 1 546
1 416
9,2% | 530
428
24% | 1 091
801
36% | 1 915
1 855
3,2% |
1 723
|
|
|
|
|
Pre-Tax Profit
(EBT)
M SEK |
Released
Forecast
Spread | 331
303
9,1% | -1 777
-865
-106% | 1 104
1 011
9,2% | 24,0
303
-92% | 205
331
-38% | 315
265
19% | 1 365
1 258
8,5% | 427
340
26% | 677
679
-0,23% | 1 841
1 596
15% |
1 629
|
490
|
438
|
940
|
1 114
|
Net income
M SEK |
Released
Forecast
Spread | 81,0
272
-70% | -1 454
-1 434
-1,4% | 713
823
-13% | 6,00
254
-98% | 103
239
-57% | 208
177
17% | 905
937
-3,5% | 271
234
16% | 494
471
5,0% | 1 380
1 124
23% |
1 116
|
333
|
298
|
639
|
757
|
EPS
SEK |
Released
Forecast
Spread | 0,30
0,79
-62% | -5,34
-5,26
-1,4% | 2,62
2,97
-12% | 0,02
0,17
-88% | 0,38
0,88
-57% | 0,76
0,67
14% | 3,32
3,44
-3,6% | 1,00
0,86
17% | 1,81
1,72
5,2% | 5,07
4,42
15% |
4,39
|
1,22
|
1,09
|
|
| | Announcement Date | 07/17/2018 | 10/18/2018 | 01/30/2019 | 04/23/2019 | 07/17/2019 | 10/18/2019 | 01/30/2020 | 04/22/2020 | 07/16/2020 | 10/16/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
GETINGE
The potential to grow through the pandemic |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
